Lantern Pharma (LTRN) Tops Q4 EPS by 1c

Lantern Pharma (NASDAQ: LTRN) reported Q4 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• Medtronic completes $550 million Scientia Vascular acquisition